{"id":"protamine","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Hypoglycemia","drugRate":"69%","severity":"common","organSystem":""},{"effect":"Headache","drugRate":"35%","severity":"common","organSystem":""},{"effect":"Influenza-like symptoms","drugRate":"13%","severity":"common","organSystem":""},{"effect":"Upper respiratory tract infection","drugRate":"12%","severity":"common","organSystem":""},{"effect":"Dyspepsia","drugRate":"9%","severity":"common","organSystem":""},{"effect":"Headache","drugRate":"9%","severity":"common","organSystem":""},{"effect":"Diarrhea","drugRate":"8%","severity":"common","organSystem":""},{"effect":"Neuropathy","drugRate":"8%","severity":"common","organSystem":""},{"effect":"Back pain","drugRate":"7%","severity":"common","organSystem":""},{"effect":"Diarrhea","drugRate":"7%","severity":"common","organSystem":""},{"effect":"Pharyngitis","drugRate":"7%","severity":"common","organSystem":""},{"effect":"Pharyngitis","drugRate":"6%","severity":"common","organSystem":""},{"effect":"Rhinitis","drugRate":"5%","severity":"common","organSystem":""},{"effect":"Skeletal pain","drugRate":"5%","severity":"common","organSystem":""},{"effect":"Upper respiratory tract infection","drugRate":"5%","severity":"common","organSystem":""},{"effect":"Abdominal pain","drugRate":"5%","severity":"common","organSystem":""},{"effect":"Rhinitis","drugRate":"5%","severity":"common","organSystem":""},{"effect":"Rash","drugRate":"","severity":"common","organSystem":""},{"effect":"Pruritus","drugRate":"","severity":"common","organSystem":""},{"effect":"Lipodystrophy","drugRate":"","severity":"common","organSystem":""}],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Severe Hypoglycemia","drugRate":"16%","severity":"serious"},{"effect":"Severe Hypoglycemia","drugRate":"4%","severity":"serious"},{"effect":"Anaphylaxis","drugRate":"","severity":"serious"},{"effect":"Worsening of diabetic retinopathy","drugRate":"","severity":"serious"},{"effect":"Acute painful peripheral neuropathy","drugRate":"","severity":"serious"},{"effect":"Ophthalmologic refraction disorder","drugRate":"","severity":"serious"},{"effect":"Erythema","drugRate":"","severity":"serious"},{"effect":"Edema","drugRate":"","severity":"serious"},{"effect":"Allergic reactions","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":{"chemblId":"CHEMBL1201651","moleculeType":"Unknown"},"aliases":["promin"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"5d9f0e10-edb9-4960-bd62-cf406e75bbe7","title":"INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [REMEDYREPACK INC.]"},"ecosystem":[],"mechanism":{},"_scrapedAt":"2026-03-28T01:30:29.277Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Heparin overdose","diseaseId":"heparin-overdose","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07477977","phase":"NA","title":"Dose for Reversal of Heparin After Cardiopulmonary Bypass","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2026-03-01","conditions":"Open Heart Surgery","enrollment":195},{"nctId":"NCT06781294","phase":"NA","title":"SIRAKI 02 Posthoc Analysis.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital Universitari de Bellvitge","startDate":"2024-10-01","conditions":"Cardiac Surgery Requiring Cardiopulmonary Bypass, Acute Kidney Injury, Chronic Kidney Disease(CKD)","enrollment":343},{"nctId":"NCT05774691","phase":"PHASE4","title":"Routine Versus Selective Protamine Administration to Reduce Bleeding Complications After Transcatheter Aortic Valve Implantation (POPular ACE TAVI)","status":"RECRUITING","sponsor":"St. Antonius Hospital","startDate":"2023-11-01","conditions":"Aortic Valve Stenosis","enrollment":1000},{"nctId":"NCT07179991","phase":"","title":"DDAVP Effect by TEG6 in Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2025-10-01","conditions":"Intraoperative Bleeding","enrollment":100},{"nctId":"NCT06215378","phase":"PHASE3","title":"Antagonization of Heparin With Protamine Sulfate After TAVI","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-05-25","conditions":"Aortic Valve Stenosis, Heart Valve Diseases","enrollment":940},{"nctId":"NCT07043556","phase":"","title":"Assessment of Artificial Intelligence Algorithms for ROTEM","status":"RECRUITING","sponsor":"Ondokuz Mayıs University","startDate":"2025-07-01","conditions":"Coagulopathy","enrollment":144},{"nctId":"NCT05484830","phase":"NA","title":"Coagulation in Acute Aortic Dissection","status":"COMPLETED","sponsor":"Ivy susanne Modrau, MD","startDate":"2022-11-01","conditions":"Acute Aortic Dissection, Coagulation Disorder","enrollment":26},{"nctId":"NCT07005661","phase":"PHASE2, PHASE3","title":"Use of PRP in Open Surgery for Type A Aortic Dissection","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-06-30","conditions":"Aortic Dissection Type A, Transfusions, Platelet Rich Plasma (PRP)","enrollment":250},{"nctId":"NCT03341156","phase":"PHASE3","title":"Administration of Prothrombin Complex Concentrate vs. Standard Transfusion During/After Heart Transplantation","status":"TERMINATED","sponsor":"University of Maryland, Baltimore","startDate":"2018-07-11","conditions":"Heart Disease End Stage, Heart Failure，Congestive","enrollment":14},{"nctId":"NCT06598280","phase":"NA","title":"Same-Day Discharge Versus Overnight Stay Following Pulmonary Vein Isolation for Atrial Fibrillation","status":"RECRUITING","sponsor":"University of Luebeck","startDate":"2025-02-20","conditions":"Atrial Fibrillation","enrollment":270},{"nctId":"NCT06328647","phase":"NA","title":"Quantra Point-of-Care Hemostasis Monitoring","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2024-10-03","conditions":"Bleeding, Hemostatic Disorder","enrollment":666},{"nctId":"NCT06230640","phase":"","title":"Evaluation of TEG 6S PM® During Cardiopulmonary Bypass to Detect Postoperative Biological Coagulopathy","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2024-07-01","conditions":"Coagulopathy, Cardiopulmonary Bypass, Cardiac Surgery","enrollment":60},{"nctId":"NCT02338947","phase":"NA","title":"Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2019-01-01","conditions":"Frail Elderly, Coronary Artery Disease","enrollment":440},{"nctId":"NCT04061798","phase":"PHASE4","title":"ACT Guided Heparinization During Open Abdominal Aortic Aneurysm Repair.","status":"TERMINATED","sponsor":"Dijklander Ziekenhuis","startDate":"2020-03-02","conditions":"Abdominal Aortic Aneurysm, Surgery, Arterial Disease","enrollment":294},{"nctId":"NCT05994989","phase":"","title":"Two Different Tranexamic Acid Regimens in Coronary Artery Bypass Surgery","status":"COMPLETED","sponsor":"Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital","startDate":"2023-08-14","conditions":"Postoperative Hemorrhage","enrollment":90},{"nctId":"NCT06619301","phase":"PHASE3","title":"RCT Glargine vs NPH for Treatment of DM in Pregnancy","status":"RECRUITING","sponsor":"Loyola University","startDate":"2024-04-01","conditions":"Diabetes Mellitus in Pregnancy, Type 2 Diabetes Mellitus (T2DM), Gestational Diabetes Mellitus, Class A2","enrollment":160},{"nctId":"NCT06565364","phase":"","title":"Immunogenicity and Thrombotic Potential of Circulating Protamine-heparin Complexes in Cardiac Surgery Patients","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2019-01-07","conditions":"Thrombocytopenia, Antibodies Drug Specific","enrollment":160},{"nctId":"NCT05426031","phase":"PHASE4","title":"Optimal Protamine Dosing for Heparin Reversal Following Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"University of Miami","startDate":"2022-06-28","conditions":"Coagulation; Intravascular","enrollment":130},{"nctId":"NCT06154018","phase":"NA","title":"Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass.","status":"COMPLETED","sponsor":"University of Ioannina","startDate":"2023-03-18","conditions":"Cardiac Surgery, CAD, Valve Heart Disease","enrollment":98},{"nctId":"NCT04437303","phase":"PHASE4","title":"Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)","status":"COMPLETED","sponsor":"St. Antonius Hospital","startDate":"2020-11-25","conditions":"Aortic Valve Disease, Aortic Valve Stenosis, Stroke","enrollment":858},{"nctId":"NCT06421792","phase":"","title":"PrOtamIne doSing clOt imagiNg (POISON) Study","status":"NOT_YET_RECRUITING","sponsor":"Papworth Hospital NHS Foundation Trust","startDate":"2024-05-08","conditions":"Cardiac Surgery","enrollment":20},{"nctId":"NCT04256668","phase":"NA","title":"Human Sperm Epigenetics in Embryonic Development.","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2020-04-01","conditions":"Male Infertility, Epigenetic Disorder","enrollment":60},{"nctId":"NCT03700801","phase":"PHASE4","title":"Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy","status":"COMPLETED","sponsor":"Zhujiang Hospital","startDate":"2018-10-01","conditions":"Type 2 Diabetes Mellitus","enrollment":130},{"nctId":"NCT05780125","phase":"PHASE2","title":"Effectiveness of Different Fibrinogen Preparations in Restoring Clot Firmness","status":"COMPLETED","sponsor":"IRCCS Policlinico S. Donato","startDate":"2023-03-20","conditions":"Hypofibrinogenemia, Surgical Blood Loss, Bleeding","enrollment":40},{"nctId":"NCT05875272","phase":"","title":"Interchangeability of Arterial Coagulation and Venous Coagulation, in the Context of Cardiac Surgeries Under Cardiopulmonary Bypass, Using the DMDiv Hemochron Signature Elite","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2023-10-01","conditions":"Hemostasis, Extracorporeal Circulation, Heparin","enrollment":201},{"nctId":"NCT06254404","phase":"NA","title":"Impact of Protamine Dose Reduction on Platelet Aggregation After Extracorporeal Circulation for Minimally Invasive Aortic Valve Replacement Surgery","status":"UNKNOWN","sponsor":"University of Liege","startDate":"2024-03-15","conditions":"Protamine Dose, Protamine Adverse Reaction","enrollment":50},{"nctId":"NCT00671008","phase":"","title":"Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-12","conditions":"Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":400},{"nctId":"NCT03954314","phase":"PHASE3","title":"DEPOSITION - Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery","status":"TERMINATED","sponsor":"Population Health Research Institute","startDate":"2019-09-17","conditions":"Bleeding, Surgical Blood Loss, Seizures","enrollment":3242},{"nctId":"NCT00101751","phase":"PHASE4","title":"INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2004-10","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":4877},{"nctId":"NCT01486862","phase":"PHASE4","title":"Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2005-10","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":26},{"nctId":"NCT00476437","phase":"PHASE3","title":"Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-04","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":81},{"nctId":"NCT05124457","phase":"PHASE2","title":"DETERMINE: Detemir vs NPH","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2022-02-01","conditions":"Gestational Diabetes, Diabetes Mellitus, Type 2","enrollment":336},{"nctId":"NCT06042738","phase":"NA","title":"Investigation of The Effectiveness of Antioxidant Therapy in Oligoasthenoteratozoospermic Infertile Men","status":"COMPLETED","sponsor":"Ondokuz Mayıs University","startDate":"2021-03-01","conditions":"Male Infertility","enrollment":48},{"nctId":"NCT03216720","phase":"NA","title":"Miniaturized Extracorporeal Circulation Study","status":"COMPLETED","sponsor":"Aarhus University Hospital Skejby","startDate":"2017-09-28","conditions":"Coronary Artery Disease","enrollment":60},{"nctId":"NCT05944107","phase":"PHASE4","title":"Anticoagulation Management in Complex Cardiac Surgery","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2021-01-01","conditions":"Extracorporeal Circulation","enrollment":65},{"nctId":"NCT05709938","phase":"PHASE4","title":"Comparison of Insulin Glargine and Regular Insulin Versus NPH and Regular Insulin in the Treatment of T1DM","status":"COMPLETED","sponsor":"King Edward Medical University","startDate":"2019-11-01","conditions":"To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children","enrollment":68},{"nctId":"NCT05708690","phase":"PHASE4","title":"Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2022-10-01","conditions":"Coronary Artery Disease, Valvular Heart Disease, Surgical Blood Loss","enrollment":132},{"nctId":"NCT04215588","phase":"NA","title":"Heparin and Protamine Titration in Cardiac Surgery Under Minimal Invasive Extracorporeal Circulation","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2019-12-20","conditions":"Cardiopulmonary Bypass","enrollment":134},{"nctId":"NCT05422170","phase":"","title":"HEParin Antagonisation in Transcatheter Aortic Valve Implantation","status":"UNKNOWN","sponsor":"Deutsches Herzzentrum Muenchen","startDate":"2022-07-01","conditions":"Aortic Valve Stenosis, Transcatheter Aortic Valve Implantation, Protamine Sulfate Overdose","enrollment":50},{"nctId":"NCT05441358","phase":"","title":"Assessment of Platelet Function in Patients Undergoing Open Heart Surgery","status":"UNKNOWN","sponsor":"LifeBridge Health","startDate":"2022-03-23","conditions":"Coronary Artery Bypass Grafting, Open Heart Surgery, Aortic Surgery or Redo Surgery","enrollment":75},{"nctId":"NCT01613807","phase":"PHASE4","title":"Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes","status":"COMPLETED","sponsor":"Sansum Diabetes Research Institute","startDate":"2008-10","conditions":"Gestational Diabetes Mellitus","enrollment":40},{"nctId":"NCT02557672","phase":"PHASE4","title":"PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2016-08","conditions":"Bleeding, Blood Loss, Surgical, Cardiovascular Surgical Procedures","enrollment":106},{"nctId":"NCT05354193","phase":"","title":"Analysis of miRNAs Expression in Vasoplegic Syndrome After On-pump Coronary Artery Bypass Surgery","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2017-08-28","conditions":"Vasoplegic Syndrome, Vasoplegia, Surgery-Complications","enrollment":320},{"nctId":"NCT02967224","phase":"PHASE4","title":"A \"Real World\" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to \"Standard of Care\" Basal Insulins in Insulin Naïve Patients Initiating Insulin","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-11-05","conditions":"Diabetes Mellitus, Type 2","enrollment":705},{"nctId":"NCT03359837","phase":"PHASE4","title":"Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-01-20","conditions":"Type 2 Diabetes Mellitus","enrollment":384},{"nctId":"NCT02967211","phase":"PHASE4","title":"A \"Real World\" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to \"Standard of Care\" Basal Insulin in Patients Already Using Basal Insulin","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-12-21","conditions":"Diabetes Mellitus, Type 2","enrollment":609},{"nctId":"NCT03916601","phase":"PHASE1","title":"Comparison of Exposure and Activity of SAR341402 Mix 70/30 to NovoLog Mix 70/30, NovoMix 30 and SAR341402 Rapid-acting Solution in Patients With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Sanofi","startDate":"2017-12-13","conditions":"Type 1 Diabetes","enrollment":52},{"nctId":"NCT05239637","phase":"NA","title":"When Heparin Stopped for Anticoagulation During ECMO Decannulation","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Zhengzhou University","startDate":"2022-02-15","conditions":"Extracorporeal Membrane Oxygenation","enrollment":40},{"nctId":"NCT04434001","phase":"PHASE2","title":"ZEPLAST- PED: ZEro_PLASma Trial in Small Infants Undergoing Cardiac Surgery","status":"TERMINATED","sponsor":"IRCCS Policlinico S. Donato","startDate":"2020-02-27","conditions":"Bleeding, Cardiac Defect, Surgery--Complications","enrollment":40},{"nctId":"NCT03620890","phase":"PHASE4","title":"Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-09-04","conditions":"Diabetes Mellitus, Type 2","enrollment":108},{"nctId":"NCT03583567","phase":"PHASE4","title":"Effect of Anti-histamine in Prevention Systolic Hypotension After Protamine","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2018-09-05","conditions":"Protamine Adverse Reaction","enrollment":40},{"nctId":"NCT03389490","phase":"PHASE4","title":"Toujeo Versus NPH Self-titration Study","status":"COMPLETED","sponsor":"Elaine Chow","startDate":"2018-01-01","conditions":"Diabetes Mellitus, Type 2","enrollment":50},{"nctId":"NCT01293396","phase":"PHASE4","title":"Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2010-06","conditions":"Type 2 Diabetes","enrollment":20},{"nctId":"NCT04092868","phase":"","title":"Heparin Antagonization by Protamine in Cardiac Surgery: Pharmacokinetic/Pharmacodynamic Study","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2019-11-13","conditions":"Cardiac Surgery Requiring Extracorporeal Circulation","enrollment":70},{"nctId":"NCT03885193","phase":"","title":"Impact of HMS Plus Device on Postoperative Blood Loss During Cardiac Surgery","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2019-05-01","conditions":"Cardiac Surgical Procedure","enrollment":188},{"nctId":"NCT04759222","phase":"","title":"Microvascular Reactivity in Cardiac Surgery","status":"COMPLETED","sponsor":"Pusan National University Hospital","startDate":"2017-02-14","conditions":"Cardiac Disease","enrollment":115},{"nctId":"NCT04700670","phase":"","title":"Evaluation of the Effect of Dextran Sulphate on Anti-Xa Activities Measured","status":"COMPLETED","sponsor":"Rennes University Hospital","startDate":"2020-01-16","conditions":"Unfractionated Heparin Treatment","enrollment":164},{"nctId":"NCT04726657","phase":"NA","title":"Comparison of Two Biphasic Insulin Regimens","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2016-01-18","conditions":"Diabetes Mellitus, Type 2","enrollment":36},{"nctId":"NCT04726631","phase":"NA","title":"Insulin in Treatment of Diabetes Mellitus With Pregnancy","status":"COMPLETED","sponsor":"Assiut University","startDate":"2015-01-01","conditions":"Diabetes","enrollment":110},{"nctId":"NCT04690309","phase":"PHASE4","title":"Human Versus Analogue Insulin in Patients After Pancreatectomy.","status":"UNKNOWN","sponsor":"Polish Society of Diabetology","startDate":"2018-07-01","conditions":"Pancreatogenous Diabetes","enrollment":100},{"nctId":"NCT03347201","phase":"NA","title":"Thrombin Generation During Cardiopulmonary Bypass With Titrated Versus Conventional Anticoagulation Management.","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2017-10-02","conditions":"Cardiac Surgery","enrollment":100},{"nctId":"NCT04628884","phase":"PHASE4","title":"Strategies for Protamine Dosing After Anticoagulation in Cardiovascular Surgery","status":"UNKNOWN","sponsor":"Fundación Clínica Shaio","startDate":"2020-11-15","conditions":"Anticoagulant Antagonist Toxicity","enrollment":136},{"nctId":"NCT02974660","phase":"PHASE4","title":"Protamine Sulfate During Transcatheter Aortic Valve Implantation","status":"COMPLETED","sponsor":"Medical University of Warsaw","startDate":"2016-12","conditions":"Aortic Valve Stenosis","enrollment":100},{"nctId":"NCT02486341","phase":"NA","title":"Daily Glycaemic Variability in Frail or Disabled Older Patients With Diabetes Over 75 Treated With Basal Insulin","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2016-03-31","conditions":"Diabetes","enrollment":30},{"nctId":"NCT03511521","phase":"PHASE4","title":"Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2018-03-27","conditions":"Hyperglycemia Steroid-induced, Insulin Resistance, Diabetes","enrollment":3},{"nctId":"NCT03862690","phase":"","title":"A Research Study, Looking at How NovoMix® Works in People With Type 2 Diabetes in Local Clinical Practice in Algeria","status":"WITHDRAWN","sponsor":"Novo Nordisk A/S","startDate":"2020-05-28","conditions":"Diabetes Mellitus, Type 2","enrollment":""},{"nctId":"NCT04034524","phase":"","title":"Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin","status":"UNKNOWN","sponsor":"Brigham and Women's Hospital","startDate":"2019-05-01","conditions":"Diabetes Mellitus, Type 2","enrollment":20000},{"nctId":"NCT02634528","phase":"PHASE1","title":"Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal","status":"COMPLETED","sponsor":"Julphar Gulf Pharmaceutical Industries","startDate":"2016-11-16","conditions":"Diabetes Mellitus","enrollment":85},{"nctId":"NCT03532594","phase":"NA","title":"Algorithmic Protamine Dosing for Reversal of Heparin After Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"Papworth Hospital NHS Foundation Trust","startDate":"2018-04-16","conditions":"Heart Diseases, Cardiovascular Diseases","enrollment":228},{"nctId":"NCT04435912","phase":"EARLY_PHASE1","title":"Hydrocortisone Per-treatment Decrease Side Effects of Protamine Sulfate","status":"COMPLETED","sponsor":"University of Jordan","startDate":"2019-07-04","conditions":"Blood Pressure, Heart Rate, Airway Pressure","enrollment":200},{"nctId":"NCT02655653","phase":"PHASE3","title":"Efficacy of Tranexamic Acid and Epsilon-aminocaproic Acid in Reducing Bleeding and Transfusions in Cardiac Surgery","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2008-10","conditions":"Bleeding","enrollment":114},{"nctId":"NCT04226105","phase":"PHASE3","title":"Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus Patients","status":"UNKNOWN","sponsor":"Geropharm","startDate":"2020-01-20","conditions":"Diabetes Mellitus, Type 2, Diabetes Mellitus","enrollment":264},{"nctId":"NCT00821795","phase":"PHASE4","title":"Veterans Inpatient Insulin Study and Transition to Outpatient Therapy","status":"COMPLETED","sponsor":"Dennis G. Karounos, M.D.","startDate":"2009-03-11","conditions":"Type 2 Diabetes Mellitus","enrollment":120},{"nctId":"NCT00854139","phase":"PHASE1","title":"Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2001-08","conditions":"Multiple Myeloma, End Stage Renal Disease","enrollment":10},{"nctId":"NCT04022304","phase":"PHASE1","title":"Comparision of Pharmacokinetic and Pharmacodynamic of Biocon Insulin N and Humulin® N","status":"COMPLETED","sponsor":"Biocon Limited","startDate":"2019-06-15","conditions":"Healthy Volunteer","enrollment":90},{"nctId":"NCT04184492","phase":"NA","title":"A Study to Compare Pharmacokinetics and Pharmacodynamics of GP-40081 to NovoMix® 30 Penfill® in Healthy Subjects","status":"COMPLETED","sponsor":"Geropharm","startDate":"2019-04-15","conditions":"Clamp Study","enrollment":34},{"nctId":"NCT02692976","phase":"PHASE2","title":"Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2015-09","conditions":"Prostatic Neoplasms, Immunotherapy, Dendritic Cells","enrollment":21},{"nctId":"NCT04159064","phase":"","title":"Impact of Cardiac Surgery With a Minimal Invasive Extracorporeal Circuit οn Coagulation: Data From Point of Care Devices","status":"COMPLETED","sponsor":"AHEPA University Hospital","startDate":"2018-12-01","conditions":"Extracorporeal Circulation; Complications, Coagulation Disorder, Extracorporeal Circulation of Blood; Thrombocytopenia","enrollment":57},{"nctId":"NCT00564018","phase":"NA","title":"Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH","status":"TERMINATED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2006-09","conditions":"Type 1 Diabetes","enrollment":33},{"nctId":"NCT01675817","phase":"","title":"Evaluation of Heparin Rebound in Cardiac Surgery","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2011-04","conditions":"Coagulation Delay","enrollment":20},{"nctId":"NCT02582242","phase":"PHASE4","title":"Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2015-10-19","conditions":"Diabetes, Type 2 Diabetes Mellitus","enrollment":437},{"nctId":"NCT02762578","phase":"PHASE3","title":"Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2016-05-03","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":543},{"nctId":"NCT03884725","phase":"PHASE4","title":"Fibrinogen Concentrate In Children Cardiac Surgery 2","status":"UNKNOWN","sponsor":"Filomena R B G Galas","startDate":"2019-03-01","conditions":"C.Surgical Procedure; Cardiac, Blood Coagulation Disorders, Hypofibrinogenemia","enrollment":42},{"nctId":"NCT01683331","phase":"PHASE4","title":"A Clinical Trial to Prevent New Onset Diabetes After Transplantation","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2012-08","conditions":"Prevention of New Onset Diabetes Among Kidney Transplant Patients","enrollment":251},{"nctId":"NCT02453685","phase":"PHASE4","title":"A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2015-08-31","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":335},{"nctId":"NCT03647644","phase":"","title":"Coagulation Test Changes Associated With Acute Normovolemic Hemodilution in Cardiac Surgery","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2018-01-31","conditions":"Coagulation Disorder, Bleeding","enrollment":80},{"nctId":"NCT03787641","phase":"NA","title":"Systematic Evaluation of Protamine Doze in Cardiac Surgery","status":"UNKNOWN","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2018-09-20","conditions":"Cardiac Surgery With Cardiopulmonary Bypass","enrollment":100},{"nctId":"NCT01059812","phase":"PHASE3","title":"A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2010-02-01","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":424},{"nctId":"NCT01009580","phase":"PHASE3","title":"Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-11-05","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":447},{"nctId":"NCT02467920","phase":"PHASE4","title":"Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM","status":"COMPLETED","sponsor":"Huazhong University of Science and Technology","startDate":"2015-08","conditions":"Type 2 Diabetes Mellitus","enrollment":349},{"nctId":"NCT02449603","phase":"PHASE4","title":"Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes","status":"COMPLETED","sponsor":"Xijing Hospital","startDate":"2015-11","conditions":"Type 2 Diabetes Mellitus","enrollment":150},{"nctId":"NCT03140631","phase":"PHASE4","title":"Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2017-03-23","conditions":"Atrial Fibrillation, Catheter Ablation","enrollment":153},{"nctId":"NCT02648217","phase":"PHASE3","title":"Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2016-01-04","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":263},{"nctId":"NCT02131272","phase":"PHASE3","title":"A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2014-06-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":42},{"nctId":"NCT03374774","phase":"","title":"A Non-interventional Study of Ability and Willingness to Pay for BIAsp 30 in a Real World Population With Type 2 Diabetes Mellitus (T2DM)","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2017-11-13","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":516},{"nctId":"NCT01184014","phase":"PHASE4","title":"Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia","status":"COMPLETED","sponsor":"HealthPartners Institute","startDate":"2010-08","conditions":"Hyperglycemia","enrollment":72},{"nctId":"NCT02012465","phase":"EARLY_PHASE1","title":"Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2013-09","conditions":"Lymphoma, Diabetes Mellitus, Type 2, Hyperglycemia","enrollment":15},{"nctId":"NCT00659282","phase":"","title":"Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatment of Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2006-09-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":57610},{"nctId":"NCT03343418","phase":"PHASE4","title":"Effects of Prophylactic Desmopressin on Blood Coagulation Parameters in Heart Valve Surgery","status":"UNKNOWN","sponsor":"Instituto do Coracao","startDate":"2015-02","conditions":"C.Surgical Procedure; Cardiac, Blood Coagulation Disorders","enrollment":108},{"nctId":"NCT02302716","phase":"PHASE3","title":"A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2014-12","conditions":"Diabetes Mellitus, Type 2","enrollment":493}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[{"date":"19921027","type":"SUPPL","sponsor":"FRESENIUS KABI USA","applicationNumber":"ANDA089454"},{"date":"19910222","type":"SUPPL","sponsor":"FRESENIUS KABI USA","applicationNumber":"ANDA089454"},{"date":"20070611","type":"SUPPL","sponsor":"FRESENIUS KABI USA","applicationNumber":"ANDA089454"},{"date":"20020301","type":"SUPPL","sponsor":"FRESENIUS KABI USA","applicationNumber":"ANDA089454"},{"date":"19900523","type":"SUPPL","sponsor":"FRESENIUS KABI USA","applicationNumber":"ANDA089454"},{"date":"19870825","type":"SUPPL","sponsor":"FRESENIUS KABI USA","applicationNumber":"ANDA089454"},{"date":"19870407","type":"ORIG","sponsor":"FRESENIUS KABI USA","applicationNumber":"ANDA089454"},{"date":"20070329","type":"SUPPL","sponsor":"FRESENIUS KABI USA","applicationNumber":"ANDA089454"},{"date":"20021205","type":"SUPPL","sponsor":"FRESENIUS KABI USA","applicationNumber":"ANDA089454"},{"date":"19991222","type":"ORIG","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20131212","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20130215","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20191115","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20070906","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20180926","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20040421","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20191115","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20130328","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20070822","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20180926","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20030630","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20040423","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20120321","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20140912","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20021025","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20090316","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20140318","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20020208","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20230721","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20070907","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20130510","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20130815","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20130612","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20051109","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20040423","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20130130","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20111030","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20031119","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20150225","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20170106","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20130311","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20150424","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20140124","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20140604","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20020405","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20140304","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20140411","type":"SUPPL","sponsor":"LILLY","applicationNumber":"BLA021017"},{"date":"20020225","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20020225","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20051114","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20230228","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20181220","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20051121","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20210428","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20041008","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20191115","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20021204","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20150417","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20170508","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20021118","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20150225","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20080903","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20020305","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20090507","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20020225","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20020626","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20070720","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20020503","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20011101","type":"ORIG","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20191115","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20021119","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20100507","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20150225","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20140904","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20080903","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20130309","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20020729","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20100507","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20121213","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20020225","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"},{"date":"20081128","type":"SUPPL","sponsor":"NOVO NORDISK INC","applicationNumber":"BLA021172"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":8866,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"protamine","genericName":"protamine","companyName":"Mustafa Kemal University","companyId":"mustafa-kemal-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Protamine is a drug classified as an inhibitor, specifically targeting heparin. It is used in clinical trials for conditions such as aortic valve disease, aortic valve stenosis, stroke, bleeding, and vascular complications, often in conjunction with oral anticoagulants or unfractionated heparin.","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"supplemented","approval_date":"1987-04-07T00:00:00.000Z","mah":"FRESENIUS KABI USA","brand_name_local":null,"application_number":"ANDA089454"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1999-12-22T00:00:00.000Z","mah":"LILLY","brand_name_local":null,"application_number":"BLA021017"},{"country_code":"US","regulator":"FDA","status":"supplemented","approval_date":"2001-11-01T00:00:00.000Z","mah":"NOVO NORDISK INC","brand_name_local":null,"application_number":"BLA021172"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}